NEURL1B Inhibitors
NEURL1B, or neuralized E3 ubiquitin protein ligase 1B, plays a crucial role in ubiquitin-dependent endocytosis, particularly within the actin cytoskeleton and cytosol. This protein is predicted to enable ubiquitin protein ligase activity, emphasizing its significance in cellular processes. To explore potential inhibitors, we considered indirect approaches targeting specific signaling pathways associated with NEURL1B. Several chemicals were identified for their ability to influence NEURL1B indirectly. For instance, PMA, a phorbol ester, activates protein kinase C (PKC), impacting NEURL1B by modulating PKC-mediated signaling, ultimately altering the ubiquitin-dependent endocytosis pathway. Chloroquine, a lysosomotropic agent, disrupts endocytosis by impairing lysosomal function, thereby indirectly inhibiting NEURL1B within the actin cytoskeleton and cytosol.
Other inhibitors, such as Brefeldin A and Wortmannin, disrupt vesicular transport and the PI3K/AKT signaling pathway, respectively, indirectly affecting NEURL1B. These alterations influence the ubiquitin-dependent endocytosis pathway and NEURL1B's function within the actin cytoskeleton. Similarly, compounds like Latrunculin B, Dynasore, and 2-Deoxyglucose impact NEURL1B by disrupting the actin cytoskeleton, endocytosis, and cellular energy metabolism, respectively. Furthermore, chemicals like Tunicamycin interfere with protein glycosylation, affecting NEURL1B indirectly by disrupting proper protein folding and trafficking. U0126, GW5074, and LY294002, targeting the MAPK and PI3K/AKT pathways, indirectly modulate NEURL1B by altering SPRY4 expression and function. In summary, understanding NEURL1B's involvement in ubiquitin-dependent endocytosis and its localization within the actin cytoskeleton provides valuable insights for identifying potential inhibitors. The presented chemicals, through their distinct mechanisms, showcase the intricate interplay of cellular pathways influencing NEURL1B and offer avenues for further exploration in the context of cellular regulation and function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate, an activator of protein kinase C (PKC), influences NEURL1B indirectly by modulating PKC-mediated signaling, impacting the ubiquitin-dependent endocytosis pathway, and altering NEURL1B activity within the actin cytoskeleton. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Inhibits NEURL1B by disrupting endocytosis through impairment of lysosomal function. By preventing proper lysosomal acidification, chloroquine interferes with the ubiquitin-dependent endocytosis pathway, consequently affecting NEURL1B function in the cytosol. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts the vesicular transport from the endoplasmic reticulum to the Golgi apparatus, indirectly inhibiting NEURL1B by altering protein trafficking. This impact on the secretory pathway influences NEURL1B localization and function within the actin cytoskeleton. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A phosphoinositide 3-kinase (PI3K) inhibitor affecting NEURL1B indirectly by disrupting the PI3K/AKT signaling pathway. This interference modulates ubiquitin-dependent endocytosis, consequently influencing NEURL1B activity within the actin cytoskeleton and cytosol. | ||||||
Latrunculin B | 76343-94-7 | sc-203318 | 1 mg | $240.00 | 29 | |
Disrupts actin polymerization, influencing NEURL1B indirectly by altering the actin cytoskeleton. This disturbance impacts NEURL1B localization and function within the cytoskeleton, affecting processes like ubiquitin-dependent endocytosis. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
A dynamin inhibitor that hinders vesicle formation during endocytosis, indirectly impacting NEURL1B. By disrupting endocytosis, dynasore influences the ubiquitin-dependent endocytosis pathway, thereby altering NEURL1B activity within the actin cytoskeleton and cytosol. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Inhibits glycolysis, indirectly affecting NEURL1B by disrupting cellular energy metabolism. The impact on energy availability influences various cellular processes, including ubiquitin-dependent endocytosis, thereby altering NEURL1B function within the actin cytoskeleton and cytosol. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Interferes with protein glycosylation, indirectly inhibiting NEURL1B by disrupting proper protein folding and trafficking. This impact on the secretory pathway influences NEURL1B localization and function within the actin cytoskeleton. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits sarco/endoplasmic reticulum Ca2+-ATPases (SERCA), indirectly influencing NEURL1B by disrupting calcium homeostasis. This impact on calcium signaling alters processes like ubiquitin-dependent endocytosis, thereby affecting NEURL1B within the actin cytoskeleton and cytosol. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
c-Raf inhibitor affecting the MAPK pathway, indirectly influencing NEURL1B. By modulating the MAPK pathway, GW5074 alters SPRY4 expression and function, indirectly impacting NEURL1B within the ubiquitin-dependent endocytosis pathway and the actin cytoskeleton. | ||||||